10 Nov 2018 ... Amarin Corp.'s fish-oil pill improved survival for high-risk cardiovascular patients in a long-term study, further evidence that the company may ...
24 Sep 2018 ... Amarin share prices nearly quadruple after the biopharmaceutical company's fish oil capsule showed dramatic benefits to heart patients in a ...
24 Sep 2018 ... Amarin Corp. ... Fish-Oil Heart Medicine Is Rarest of Drug Breakthroughs ... niche patient groups, and their impact is further restricted by price.
24 Jul 2019 ... Amarin is betting big on its fish-oil derivative Vascepa with a $400 ... A nod of approval from a U.S. cost watchdog could kick those hopes into ...
29 May 2019 ... Amarin shares surged after the company said the FDA agreed to an expedited review of its prescription-strength fish oil pill for patients at risk of ...
18 Mar 2019 ... Amarin's High-Dose Fish Oil Pill Cuts Total CV Event Risk 30% in Study ... it's pretty likely this will be cost-effective at the current price point of ...
10 Nov 2018 ... Fresh results have confirmed the heart-protecting benefits of Vascepa, the prescription drug derived from fish oil from Amarin.
12 Nov 2018 ... Shares of Amarin fell Monday despite the fish oil drug Vascepa's ... that percentage is also attributable to the shares' historically low prices).
AMRN: Get the latest Amarin stock price and detailed information including AMRN news, ... It has developed and markets Vascepa capsules through wholesale.